HES1 and central nervous system cancer: Of note, since MRK003 treatment caused a severe suppression in Hes1/Hey1 expression in some of the studied cells, we acknowledge that the proposed biomarkers may only be used to monitor glioma cells ́ responsiveness to BRON, but their blockade does not explain the impaired cell invasion.